IDEX (IEX) Q2 2026 earnings review

Record Orders and a Tariff Windfall Drive Raised Guidance

IDEX printed a massive top-line indicator this quarter: orders eclipsed $1 billion for the first time, propelling an accelerating 28% organic order growth rate. Revenue followed with a stable 5% organic increase. Operating leverage and a significant, one-time tariff refund pushed Adjusted EPS up 12% to $2.32, beating expectations. This record demand profile gave management the confidence to raise full-year organic growth guidance to 5-6%. However, beneath the headline beat, growth is fiercely bifurcated. The Health & Science Technologies (HST) segment is soaring on AI data center and semiconductor demand, while the industrial and safety segments (FMT and FSDP) are barely treading water and masking underlying margin decay.

🐂 Bull Case

Unprecedented Demand Spikes in Key Markets

The HST segment is capturing intense secular tailwinds from AI data centers, space, and defense, driving a record $1.07B total corporate order book that significantly de-risks forward revenue targets.

Raised Full-Year Outlook

Management increased FY26 organic growth guidance from 3-4% up to 5-6%, signaling high visibility and confidence that Q2's order surge will convert cleanly in the second half of the year.

🐻 Bear Case

Low Quality Margin Expansion

The reported 110 bps expansion in Adjusted Gross Margin is heavily distorted by a one-time IEEPA tariff refund. Without this 150 bps tailwind, underlying gross margins actually contracted.

Industrial Stagnation Persists

FSDP segment sales shrank 1% organically, and FMT margins are facing severe mix headwinds due to persistent softness in core agricultural, chemical, and energy end markets.

⚖️ Verdict: 🟢

Bullish. While the margin quality this quarter is muddied by tariff adjustments and mix headwinds in legacy segments, the sheer magnitude of the 28% organic order growth in advantaged markets creates an undeniable runway for future earnings power.

Key Themes

DRIVER 🟢🟢

AI and Semiconductor Demand Fueling HST

The Health & Science Technologies (HST) segment is the undisputed growth engine. Organic sales grew 12% and segment Adjusted EBITDA margin expanded 270 bps to 28.7%. The growth rate is accelerating, driven directly by AI-driven demand for data center liquid cooling and on-site power, alongside robust semiconductor metrology requirements. Integrations of recent acquisitions like Micro-LAM and Mott are scaling rapidly.

DRIVER 🟢

Intelligent Water and Mining Resiliency

Within the Fluid & Metering Technologies (FMT) segment, intelligent water platforms and mining end markets provided a stable growth floor. These gains narrowly offset broader volume declines in energy, agriculture, and chemical markets, allowing the segment to post a positive 1% organic growth rate.

DRIVER 🟢

80/20 Principles Unlocking Cash Flow

IDEX's aggressive deployment of its 80/20 operational framework continues to guard structural cash flow efficiency. Free cash flow accelerated 20% year-over-year to $177M (a 103% conversion rate). This reliable cash generation fully funded $77M in share repurchases and $54M in dividends during the quarter.

THEME 🔴

Bifurcated Industrial Economy

Management's successful pivot to 'advantaged markets' (data centers, space) is currently masking a deeply stagnant general industrial environment. End markets like chemical, agriculture, and broader industrial remain in a prolonged lull. This macro bifurcation forces the company to rely heavily on its niche tech sectors to hit overall targets.

CONCERN 🔴

FSDP Segment Continues to Lag

The Fire & Safety/Diversified Products (FSDP) segment is pulling down the corporate average. Organic sales decelerated to a 1% decline, hampered by lower European rescue demand and persistent sluggishness in the Dispensing business. Compounding the volume drop, Adjusted EBITDA margins fell 50 bps to 28.9%.

CONCERN NEW 🔴

One-Time Tariff Refunds Mask Underlying Margin Pressures

The company reported a 110 bps expansion in Adjusted Gross Margin, citing productivity and volume leverage. However, this contradicts the underlying data: 150 bps of this expansion came from a one-time IEEPA tariff refund ($22M COGS reduction vs $14.7M in customer rebates). Excluding this non-recurring windfall, true gross margins actually contracted by 40 bps due to unfavorable mix.

CONCERN NEW 🔴

FMT Margins Suffer from Severe Mix Headwinds

Despite receiving a massive 180 bps tailwind from the IEEPA tariff refund, the FMT segment's Adjusted EBITDA margin still declined by 20 bps YoY to 34.8%. This points to a severe, decelerating underlying margin profile—effectively a 200 bps core contraction—driven by volume deleverage in higher-margin legacy energy and chemical portfolios.

Other KPIs

Record Orders $1.07 Billion

Accelerating dramatically. Organic order growth reached 28%, significantly outstripping the 5% organic sales growth. This implies a rapidly expanding backlog, heavily concentrated in the HST segment, which drastically de-risks management's raised revenue guidance for the back half of the year.

Consolidated Adjusted EBITDA $258.3 Million

Accelerating 9% YoY. Adjusted EBITDA margin stepped up 70 bps to 28.1%. However, this includes a $7.3M net benefit from tariff refunds. Excluding the tariff dynamic, margins would have faced slight compression due to the dilutive mix effect of recent, fast-growing (but lower margin) acquisitions.

Guidance

FY26 Organic Sales Growth 5% to 6%

Accelerating. Management raised the full-year target from the prior 3-4% range, fully fueled by the massive $1B+ order book generated in Q2. This represents a significant step-up from FY25's 1% print.

FY26 Adjusted EPS $8.70 - $8.85

Accelerating. Raised significantly from the prior $8.35-$8.55 range. The new midpoint ($8.77) implies roughly 10% YoY growth, assuming strong flow-through from the elevated backlog and a stabilization of industrial mix.

Q3 26 Organic Sales Growth 5% to 7%

Stable to Accelerating sequentially compared to the 5% achieved in Q2. This indicates high confidence that the current burst in HST orders will convert to recognized revenue seamlessly over the summer.

Q3 26 Adjusted EPS $2.20 - $2.25

Stable. The sequential step down from Q2's $2.32 is largely mechanical, as Q2 included the one-time $0.08 EPS benefit from the IEEPA tariff refund. The core operational run-rate remains steady.

Key Questions

True Margin Baseline Ex-Tariffs

The IEEPA tariff refund contributed 130 bps to overall Adjusted EBITDA margins this quarter. Excluding this, core margins appear to be contracting due to mix. When do you expect structural, mix-driven margin expansion to return?

Order Conversion Timeline

With organic orders surging 28% but Q3 organic sales guided to only 5-7%, what proportion of the record $1.07B order book represents long-cycle delivery stretching into late 2026 or 2027?

FSDP Structural Weakness

The FSDP segment saw noted weakness in European rescue demand. Is this a temporary budget timing issue, or a structural shift in municipal spending priorities across the continent?

M&A Margin Dilution

Are the 80/20 initiatives actively elevating the margin profiles of recent high-growth acquisitions like Micro-LAM and Mott, or are those businesses still operating at levels dilutive to the HST segment average?